Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...
Guardado en:
Autores principales: | Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
por: John M. S. Bartlett, et al.
Publicado: (2021) -
Pathway-based subnetworks enable cross-disease biomarker discovery
por: Syed Haider, et al.
Publicado: (2018) -
Stratified coastal ocean interactions with tropical cyclones
por: S. M. Glenn, et al.
Publicado: (2016) -
Using nuclear receptor activity to stratify hepatocarcinogens.
por: Imran Shah, et al.
Publicado: (2011) -
On-chip spectrometers using stratified waveguide filters
por: Ang Li, et al.
Publicado: (2021)